CYP2S1 rs338599 polymorphism confers reduced risk to anti‐tuberculosis drug‐induced liver injury and may be a novel marker for its risk prediction

PURPOSE: In the present study, we would like to explore whether Cytochrome P450 2S1 (CYP2S1) rs338599 polymorphism confers risk to anti‐tuberculosis drug‐induced liver injury (ADLI) and provide evidence of being used as novel marker for ADLI risk prediction. PATIENTS AND METHODS: A total of 162 pulm...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liyuan, Wang, Hui, Qi, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169199/
https://www.ncbi.nlm.nih.gov/pubmed/35535391
http://dx.doi.org/10.1002/jcla.24478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169199/
https://www.ncbi.nlm.nih.gov/pubmed/35535391
http://dx.doi.org/10.1002/jcla.24478

Ejemplares similares